With more states reporting record numbers of new infections of coronavirus disease 2019 (COVID-19), the United States has surpassed 3 million confirmed cases; the Trump administration has notified the United Nations that it will be withdrawing from the World Health Organization (WHO); a new injectable given to patients every 2 months can protect against HIV better than the commonly used daily pill.
With more states reporting record numbers of new infections of coronavirus disease 2019 (COVID-19), the United States has surpassed 3 million confirmed cases, according to Reuters. California, Hawaii, Idaho, Missouri, Montana, Oklahoma, and Texas all easily surpassed previous daily records for new cases, and Texas and California each had more than 10,000. The rise in cases has led to more Americans seeking COVID-19 screenings, and HHS has added short-term testing sites in Florida, Louisiana, and Texas.
The Trump administration has notified the United Nations that it will be withdrawing from the World Health Organization (WHO) over its response to the COVID-19 pandemic. The Associated Press reported that health officials and critics of the administration blasted the move, saying it would cost the United States influence globally. The withdrawal would not take effect until next year and if former Vice President Joe Biden, the presumptive Democratic presidential nominee, wins in the November election, he could rescind the decision.
A new injectable given to patients every 2 months can protect against HIV better than the commonly used daily pill, according to researchers. The high price for daily HIV prevention pills like Truvada and Descovy has highlighted the need for other prevention options, The New York Times reported. The trial evaluating the long-acting injectable, cabotegravir, was stopped in May after an interim analysis showed it was highly effective. The shot taken every 2 months was 66% more effective than Truvada.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More